From: Zotepine loaded lipid nanoparticles for oral delivery: development, characterization, and in vivo pharmacokinetic studies
Condition
Size (nm)
PDI
ZP (mV)
Assay (mg)
EE (%)
Pre-lyo
109.4 ± 1.7
0.18 ± 0.03
− 30.1 ± 1.9
9.9 ± 0.2
98.0 ± 2.1
Post-lyo
272.8 ± 4.1
0.42 ± 0.09
− 29.5 ± 2.1
9.8 ± 0.1
97.9 ± 2.8